NCT06772701 Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
| NCT ID | NCT06772701 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Groupe Hospitalier du Havre |
| Condition | Depression, Postpartum |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-07-11 |
| Primary Completion | 2027-01-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2024-07-11 with a primary completion date of 2027-01-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In recent years, fatherhood has changed considerably. Fathers are now more involved during the perinatal period, with their partner but also in caring for the child. Investigators now know that this period is also a source of major psychological upheaval, identity crisis, apprehension and anxiety for men. These upheavals can lead to depression that must be detected and treated as early as possible. This is an easy screening to perform using the EPDS (Edinburgh Postnatal Depression Scale). Currently, the EPDS is the most widely used self-questionnaire to assess the risk of depression in women during the perinatal period. Indeed, it is systematically recommended in many countries. It is starting to be used for the same purpose in the perinatal period in men, although the scale has not been validated in a representative sample of men in the pre- or post-natal period. The main objective is to validate the use of the EPDS scale as a screening tool for postnatal depression in a population of French fathers. They complete the PH-Q9, EPDS and socio-demographic questionnaires online at inclusion and 6 to 8 weeks after the birth of their child. Fathers included at the maternity ward also too Mini International Neuropsychiatric Interview (MINI) at inclusion.
Eligibility Criteria
Inclusion Criteria: * All fathers whose baby is 10 days old or less Exclusion Criteria: * People with a poor understanding of spoken or written French * Minors * Persons under court protection, guardianship or curatorship
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06772701 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Depression, Postpartum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06772701 currently recruiting?
Yes, NCT06772701 is actively recruiting participants. Contact the research team at angelique.picard@ch-havre.fr for enrollment information.
Where is the NCT06772701 trial being conducted?
This trial is being conducted at Clamart, France, Montivilliers, France.
Who is sponsoring the NCT06772701 clinical trial?
NCT06772701 is sponsored by Groupe Hospitalier du Havre. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.